Keyphrases
1H-MRS
8%
At-risk Mental State
12%
Cerebral White Matter
9%
Clinical High Risk
24%
Clinical High Risk for Psychosis (CHR-P)
39%
Clinical Outcomes
14%
Clinical Symptoms
12%
Cognitive Behavioral Therapy
13%
Cognitive Deficits
13%
Cognitive Function
13%
Cognitive Functioning
10%
Cognitive Impairment
10%
Cognitive Remediation
24%
Cognitive Training
8%
Comprehensive Assessment
10%
Emotion Recognition
10%
Fractional Anisotropy
22%
Functional Outcome
14%
GABA Level
8%
Glutamate
17%
Healthy Controls
28%
High Risk
9%
High-risk Individuals
34%
Meta-analysis
12%
Mood Disorders
7%
Negative Symptoms
29%
Neurocognition
16%
Paranoid Ideation
8%
Patients with Schizophrenia
9%
Pilot Randomized Controlled Trial
8%
Processing Speed
10%
Psychosis
37%
Psychosis Onset
8%
Psychotic Disorders
12%
Quality of Life
8%
Randomized Clinical Trial
26%
Real-world Functioning
11%
Review Analysis
8%
Schizophrenia
24%
Schizophrenia Spectrum Disorders
33%
Schizotypal Disorder
9%
Social Cognition
8%
Social Functioning
14%
Social Skills
10%
Transition to Psychosis
13%
Ultra-high Risk
59%
Ultra-high Risk for Psychosis
100%
Virtual Reality
29%
White Matter
8%
γ-aminobutyric Acid
8%
Psychology
Cognitive Behavioral Therapy
8%
Cognitive Deficit
22%
Cognitive Function
21%
Cognitive Functioning
11%
Cognitive Impairment
18%
Composite Score
7%
Cortisol
5%
Executive Functions
7%
High-Risk Population
9%
Learning and Memory
7%
Linear Regression
6%
Long-Term Outcome
6%
Longitudinal Study
6%
Mental State
14%
Meta-Analysis
5%
Mixed Methods
8%
Mood
7%
Mood Disorder
8%
Negative Affect
5%
Processing Speed
15%
Psychotic Disorder
21%
Quality of Life
18%
Rating Scale
7%
Regression Analysis
13%
Schizophrenia
43%
Social Challenge
7%
Social Cognition
19%
Social Functioning
26%
Structured Interview
5%
Substance Abuse
5%
Systematic Review
10%
Theory of Mind
5%
Working Memory
9%